Literature DB >> 8595487

Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss.

C A Davie1, G J Barker, S Webb, P S Tofts, A J Thompson, A E Harding, W I McDonald, D H Miller.   

Abstract

Proton magnetic resonance spectroscopy (MRS) and MRI were carried out in 11 patients with multiple sclerosis who had clinical evidence of severe cerebellar involvement, 11 multiple sclerosis patients (of similar age and disease duration) who had minimal or no signs of cerebellar disease, eight patients with autosomal dominant cerebellar ataxia (ADCA) and 11 healthy controls. In all subjects MRS was localized to cerebellar white matter (volumes of interest 3-6 ml). Apparent metabolite concentrations were calculated using the fully relaxed water spectrum as an internal standard of reference. The patients also underwent MRI to assess cerebellar volume and (in the two multiple sclerosis groups) lesion volume within the posterior fossa. Magnetic resonance spectroscopy from cerebellar white matter showed a highly significant reduction in the concentration of N-acetyl groups (NA) [which consists predominantly of N-acetylaspartate (NAA), a neuronal marker] in the multiple sclerosis group with cerebellar deficit compared with the multiple sclerosis group with minimal or no signs of cerebellar involvement, and healthy controls. Follow-up MRS performed in six of the multiple sclerosis patients 9 months later showed no change in the median NA concentration. The ADCA group showed a significant reduction of NA from a region of cerebellar white matter and also a reduction in the concentration of choline-containing compounds. The multiple sclerosis group with severe cerebellar deficit and the ADCA group both had significant cerebellar atrophy (suggesting nerve cell body and axon loss) compared with the multiple sclerosis patients with minimal or no signs of cerebellar deficit and healthy controls. The multiple sclerosis patients with cerebellar deficit had a significantly greater lesion volume in the posterior fossa, although the proportion of the spectroscopic voxel occupied by lesions was small, suggesting that axonal loss from normal appearing white matter also contributes to the observed reduction in NA. These results support the hypothesis that axonal loss is important in the development of persistent clinical disability in multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8595487     DOI: 10.1093/brain/118.6.1583

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  65 in total

1.  Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis.

Authors:  D B McGavern; P D Murray; C Rivera-Quiñones; J D Schmelzer; P A Low; M Rodriguez
Journal:  Brain       Date:  2000-03       Impact factor: 13.501

Review 2.  Neurological rehabilitation: from mechanisms to management.

Authors:  A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-12       Impact factor: 10.154

3.  Regional metabolite levels of the normal posterior fossa studied by proton chemical shift imaging.

Authors:  D Galanaud; Y Le Fur; F Nicoli; B Denis; S Confort-Gouny; J P Ranjeva; P Viout; J Pelletier; P J Cozzone
Journal:  MAGMA       Date:  2001-10       Impact factor: 2.310

4.  Abnormal Purkinje cell activity in vivo in experimental allergic encephalomyelitis.

Authors:  Carl Y Saab; Matthew J Craner; Yuko Kataoka; Stephen G Waxman
Journal:  Exp Brain Res       Date:  2004-04-29       Impact factor: 1.972

Review 5.  Cell therapy in demyelinating diseases.

Authors:  Claire Rice; Christopher Halfpenny; Neil Scolding
Journal:  NeuroRx       Date:  2004-10

Review 6.  Strategies for achieving and monitoring myelin repair.

Authors:  Claire Rice; Neil Scolding
Journal:  J Neurol       Date:  2007-03-07       Impact factor: 4.849

7.  Rapid automatic segmentation of the human cerebellum and its lobules (RASCAL)--implementation and application of the patch-based label-fusion technique with a template library to segment the human cerebellum.

Authors:  Katrin Weier; Vladimir Fonov; Karyne Lavoie; Julien Doyon; D Louis Collins
Journal:  Hum Brain Mapp       Date:  2014-04-28       Impact factor: 5.038

8.  Axonal degeneration and progressive neurologic disability in multiple sclerosis.

Authors:  Carl Bjartmar; Bruce D Trapp
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

9.  Pyramidal tract mapping by diffusion tensor magnetic resonance imaging in multiple sclerosis: improving correlations with disability.

Authors:  M Wilson; C R Tench; P S Morgan; L D Blumhardt
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

10.  Analysis of 45 candidate genes for disease modifying activity in multiple sclerosis.

Authors:  Sreeram V Ramagopalan; Gabriele C Deluca; Katie M Morrison; Blanca M Herrera; David A Dyment; Matthew R Lincoln; Sarah-Michelle Orton; Michael J Chao; Alexandra Degenhardt; Maura Pugliatti; A Dessa Sadovnick; Stefano Sotgiu; George C Ebers
Journal:  J Neurol       Date:  2008-06-20       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.